Collectively, the findings from this study suggest that ATP6V1A/BNIP3/CAMK4/TIPRL/TOMM70 are associated with mitochondrial dysfunction, inflammatory processes, and various pathways involved in AD pathogenesis. Here, CAMK4 is linked to Alzheimer disease.